Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

U S Physical Therapy (USPH) Cash from Financing Activities (2016 - 2025)

U S Physical Therapy's Cash from Financing Activities history spans 12 years, with the latest figure at -$13.3 million for Q4 2023.

  • For Q4 2023, Cash from Financing Activities fell 167.17% year-over-year to -$13.3 million; the TTM value through Dec 2023 reached $84.3 million, up 227.14%, while the annual FY2025 figure was -$44.1 million, 19.44% down from the prior year.
  • Cash from Financing Activities for Q4 2023 was -$13.3 million at U S Physical Therapy, down from -$12.5 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $107.7 million in Q2 2023 and bottomed at -$75.8 million in Q2 2020.
  • The 5-year median for Cash from Financing Activities is -$5.0 million (2022), against an average of $4.5 million.
  • The largest annual shift saw Cash from Financing Activities crashed 475.81% in 2020 before it skyrocketed 5548.84% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at -$14.3 million in 2019, then surged by 139.85% to $5.7 million in 2020, then soared by 1190.5% to $73.4 million in 2021, then crashed by 73.05% to $19.8 million in 2022, then tumbled by 167.17% to -$13.3 million in 2023.
  • Per Business Quant, the three most recent readings for USPH's Cash from Financing Activities are -$13.3 million (Q4 2023), -$12.5 million (Q3 2023), and $107.7 million (Q2 2023).